This review highlights the causal link between cardiomyocyte apoptosis and heart failure, suggesting potential therapeutic targets.
Answers are grounded in this paper and cite their sources.
Apoptosis may be a viable HF therapeutic target; leaves open whether inhibitors improve patient outcomes.
Recently, low -but abnormal -rates of cardiomyocyte apoptosis have been observed in failing human hearts. Genetic and pharmacological studies suggest that this cell death is causally linked to heart failure in rodent models. Herein, we review these data and discuss potential therapeutic implications.
No takes yet. Share an insight, caveat, or question.
Foo et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: